GelStat (OTCPK:GSAC) - Stock Price, News & Analysis

GSAC Stock Overview

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. More details

GSAC fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Shareholders have been substantially diluted in the past year

Makes less than USD$1m in revenue ($212K)

Has less than 1 year of cash runway

Does not have a meaningful market cap ($897K)

+ 3 more risks

GelStat Corp. Competitors

Target Group

OTCPK:CBDY

US$1.5m

Bespoke Extracts

OTCPK:BSPK

US$1.2m

Resonate Blends

OTCPK:KOAN

US$502.0k

SciSparc

NasdaqCM:SPRC

US$1.0m

Price History & Performance

Summary of all time highs, changes and price drops for GelStat
Historical stock prices
Current Share Price	US$0.0004
52 Week High	US$0.0006
52 Week Low	US$0.0002
Beta	2.03
11 Month Change	0%
3 Month Change	33.33%
1 Year Change	0%
33 Year Change	-97.84%
5 Year Change	-75.00%
Change since IPO	-99.93%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	GSAC	US Pharmaceuticals	US Market
7D	0%	1.6%	2.2%
1Y	0%	10.0%	31.7%

Return vs Industry: GSAC underperformed the US Pharmaceuticals industry which returned 10.8% over the past year.

Return vs Market: GSAC underperformed the US Market which returned 31.1% over the past year.

Price Volatility

Is GSAC's price volatile compared to industry and market?
GSAC volatility
GSAC Average Weekly Movement	44.9%
Pharmaceuticals Industry Average Movement	9.7%
Market Average Movement	6.3%
10% most volatile stocks in US Market	15.8%
10% least volatile stocks in US Market	3.1%

Stable Share Price: GSAC's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: GSAC's weekly volatility has increased from 38% to 45% over the past year.

About the Company

Founded	Employees	CEO	Website
2002	2	Javier Acosta	www.gelstat.com

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers.

GelStat Corp. Fundamentals Summary

How do GelStat's earnings and revenue compare to its market cap?
GSAC fundamental statistics
Market cap	US$897.13k
Earnings (TTM)	-US$346.05k
Revenue (TTM)	US$212.38k

5.6x

P/S Ratio

-3.5x

P/E Ratio

Is GSAC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GSAC income statement (TTM)
Revenue	US$212.38k
Cost of Revenue	US$39.38k
Gross Profit	US$172.99k
Other Expenses	US$519.05k
Earnings	-US$346.05k

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.00012
Gross Margin	81.46%
Net Profit Margin	-162.94%
Debt/Equity Ratio	-58.6%

How did GSAC perform over the long term?

See historical performance and comparison